RenovoRx (RNXT) Deferred Taxes (2024)
RenovoRx (RNXT) posted Deferred Taxes of $128000.0 for Q2 2024, up 574.07% sequentially from -$27000.0 in Q1 2024.
RenovoRx (RNXT) Deferred Taxes (2024) Analysis & Trends
RenovoRx has reported Deferred Taxes for 1 years, with the latest figure at $128000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | - |
| 10 | RenovoRx | 61.70 Mn | 61.70 Mn | 766,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | -27,000.00 |